Latest News for: cns
Edit
Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small ...
Business Wire 20 Dec 2025
T .
Edit
Support CN’s Middle East Coverage
Consortium News 20 Dec 2025
Shares. Seven-year old Consortium News in 2002 was one of the first outlets to reject the politicized intelligence for the disasters Iraq invasion and has run circles around corporate media on Syria and Gaza. But only with your help. April 18,1991 ... .
Edit
NeuraWorx Closes Oversubscribed Seed Round Led by Nexus NeuroTech to Advance Neurotechnology Therapy for CNS Disorders
Business Wire 19 Dec 2025
Edit
Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS Disorders - ResearchAndMarkets.com
Pharmiweb 19 Dec 2025
... (Neurodegenerative Disorders, Mental Health, Neurovascular Diseases, CNS Trauma, CNS Cancer, Other Disease Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).
Edit
CNS Pharmaceuticals Announces CEO Transition (CNS Pharmaceuticals Inc)
Public Technologies 17 Dec 2025
HOUSTON, TX / ACCESS Newswire / December 17, 2025 / CNS Pharmaceuticals, Inc ... "We are grateful to John and his dedicated service to CNS Pharmaceuticals and wish him all the best in his next endeavors ... About CNS Pharmaceuticals, Inc.
Edit
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Nasdaq Globe Newswire 16 Dec 2025
Edit
The Galveston Daily News
15 Dec 2025
Udemy and LG CNS Partner to Deliver End-to-End Upskilling for Enterprises in Korea, Accelerating Workforce Transformation
Edit
CONCLUSION OF CNS VISIT TO BRAZIL (Ministry of Defence of the Republic of India)
Public Technologies 15 Dec 2025
Edit
Ophidion, Inc. and Neuronasal, Inc. Announce Strategic Collaborations to Tackle Parkinson’s Disease, Obesity, and Diabetes via Novel CNS Delivery Platform
Pharmiweb 15 Dec 2025
“We are excited to partner with Neuronasal and advance these therapeutics with our Central Nervous System (CNS)-delivery platform,” said Yacoub Habib, CEO of Ophidion ... Ophidion is an early-stage CNS ...
Edit
The Elkin Tribune
11 Dec 2025
Formation Bio Licenses Phase 1-Ready CNS Penetrant TYK2 Inhibitor from Lynk Pharmaceuticals
Acquisition adds a highly differentiated clinical stage asset to Formation Bio's rapidly expanding portfolio of immunology programs ... .
Edit
CNS Delivery Summit Dec 2025 (Arrowhead Pharmaceuticals Inc)
Public Technologies 10 Dec 2025
). TRiM Platform for Delivery of RNAi Therapeutics. to Central Nervous System via Subcutaneous Administration. Agnieszka Glebocka, Ph.D ... For investor communication only ... Liver ... Lung ... CNS ... Common feature of CNS diseases ... BBB Platform for siRNA Delivery to CNS.
Edit
ORIC� Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in ...
Nasdaq Globe Newswire 05 Dec 2025- 1
- 2
- Next page »